iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Granules India Ltd Peer Comparison

592.95
(-0.65%)
Dec 26, 2024|03:31:20 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

GRANULES INDIA LTD PEER COMPARISON

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,819

158.194,36,103.12863.290.745,123.6798.33

Divis Laboratories Ltd

DIVISLAB

5,782.35

83.581,53,540.395180.522,302513.62

Mankind Pharma Ltd

MANKIND

2,910.6

59.911,20,073.47634.4302,529.74334.18

Cipla Ltd

CIPLA

1,475.75

28.161,19,195.761,178.160.883,969.86360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,399.45

70.361,15,106.894600.822,376222.38

Granules India: RELATED NEWS

Granules India Secures USFDA Approval for Andhra Facility
12 Nov 2024|10:14 AM

The inspection covered Active Pharmaceutical Ingredients (APIs) and Finished Dosages (FDs) for oncology and non-oncology segments, underscoring the plant’s adherence to high manufacturing standards.

Read More
Granules India Secures USFDA Nod for Bupropion SR Tablets
20 Oct 2024|07:33 PM

Bupropion hydrochloride is widely prescribed for treating major depressive disorder (MDD) and preventing seasonal affective disorder (SAD).

Read More
Granules India’s Gagilapur unit gets 6 observations from USFDA
12 Sep 2024|03:26 PM

The USFDA has also noted a repeat observation from the company's January 2023 inspection.

Read More
Granules India Gets USFDA Nod for Pediatric Glycopyrrolate Oral Solution
21 Aug 2024|03:13 PM

Glycopyrrolate Oral Solution is an anticholinergic medication used to treat pediatric patients aged 3 to 16 years with neurological conditions that cause drooling.

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp